Literature DB >> 4217816

Some factors affecting the detection of long-acting thyroid stimulator protector using the McKenzie bioassay.

S Dirmikis.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4217816     DOI： 10.1677/joe.0.0630427

Source DB:  PubMed          Journal:  J Endocrinol        ISSN： 0022-0795            Impact factor:   4.286


× No keyword cloud information.
  6 in total

1.  Editorial: hyperthyroidism and Grave's disease.

Authors: 
Journal:  Br Med J       Date:  1975-05-31

2.  Letter: Neonatal hyperthyroidism and long-acting thyroid stimulator protector.

Authors:  J A Thomson; D S Dirmikis; D S Munro; B R Smith; R Hall; E D Mukhtar
Journal:  Br Med J       Date:  1975-04-05

3.  Absence of allotypic variation in the autoantigen for thyroid stimulating autoantibodies.

Authors:  A Knight; D D Adams
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

4.  Serum long acting thyroid stimulator (LATS) and LATS-protector (LATS-P) in Graves' disease associated with localized myxedema.

Authors:  C A Hardisty; A Fowles; D S Munro
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

5.  Placental transmission of thyroid-stimulating immunoglobulins.

Authors:  S M Dirmikis; D S Munro
Journal:  Br Med J       Date:  1975-06-21

6.  Serum long acting thyroid stimulator protector in pregnancy complicated by Graves' disease.

Authors:  C A Hardisty; D S Munro
Journal:  Br Med J (Clin Res Ed)       Date:  1983-03-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.